AGMFor those that haven't opened the AGM notice.
THERALASE
TECHNOLOGIES INC. NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
TO THE SHAREHOLDERS:
NOTICE IS HEREBY GIVEN that the Annual General and Special Meeting (the “Meeting”) of the Shareholders of Theralase
Technologies Inc. (the "Corporation") will be held on Thursday June 29th, 2023 at 4:30 pm (Toronto time) at 41 Hollinger
Road, Toronto, Ontario, Canada, for the purposes of:
a) electing directors of the Corporation for the ensuing year;
b) appointing the auditors of the Corporation for the ensuing year and authorizing the directors, acting through the
Audit Committee, to fix the remuneration to be paid to the auditors;
c) receiving and considering the audited consolidated financial statements for the fiscal year ended December 31,
2022 and the report of the auditors thereon;
d) re-approving the Corporation’s Incentive Stock Option Plan, as described in the Management Information Circular;
e) transacting such other business as may properly come before the Meeting.
Only registered shareholders of record as of the close of business on May 19th, 2023, the record date for the Meeting, are
entitled to receive notice of and to attend and vote at the Meeting.
Shareholders are strongly encouraged to vote via proxy in advance of the Meeting, and are requested to date, sign and
return the accompanying Instrument of Proxy, in accordance with the instructions contained in the accompanying
Management Information Circular, to the offices of TSX Trust Company, Proxy Department, 100 Adelaide Street West, Suite
301, Toronto, Ontario, M5H 4H1, not less than 48 hours before the time fixed for holding the Meeting, or any adjournment
thereof, or to the Chairman of the Meeting immediately prior to the commencement of the Meeting, or any adjournment
thereof.
DATED at Toronto, Ontario this 24th day of May, 2023.
BY ORDER OF THE BOARD OF DIRECTORS:
Kristina Hachey
Chief Financial Officer